Supportive and palliative care
A156 – A178
- A156: The elephant in the room: how much do oncologists tell patients about the survival benefits of palliative chemotherapy?
- A157: Abstract withdrawn
- A158: The development of a Patients Concerns Inventory (PCI) as a means of improving out-patient consultation and patient empowerment
- A159: User involvement in a research collaborative: progress through participation
- A160: The development of a side effect risk modelling tool for use in patients with breast cancer receiving adjuvant chemotherapy (ASyMS-SERAT)
- A161: Hospital Anxiety and Depression Scale (HADS) mood screening in neuro-oncology patients
- A162: Supportive care in cancer management
- A163: The efficacy of oral dietary interventions in the management of weight loss in patients with cancer: a systematic review
- A164: Implementing and evaluating a four tier model of psychological support. Results from a three year study
- A165: A psychoeducational groups for patients at the end of adjuvant treatment
- A166: A qualitative study of hospice patients’ perceptions of spiritual need and spiritual care provision
- A167: Comparison of red-cell transfusion requirement following restriction of erythropoiesis-stimulating agents in oncology patients
- A168: Screening for social difficulties: guidelines for oncology staff
- A169: Self care and advanced cancer- the patients experience
- A170: Preferences for end-of life care: a systematic appraisal of the research evidence 1997-2007
- A171: Utility of carboplatin as second line chemotherapy for advanced melanoma: a two centre audit
- A172: Life after cancer treatment: self management following active treatment for cancer
- A173: Exploring the breast cancer experiences, needs and preferences of women aged 70 years and over
- A174: Chickenpox in varicella IgG positive patients: experience of a regional paediatric oncology centre
- A175: A UK institution’s 10 year experience of treating intracranial metastatic disease from melanoma
- A176: Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study
- A177: Management of refractory ascites associated with malignant tumor with Denver peritoneo-venous shunt (PVS)
- A178: A qualitative analysis of the impact of insomnia secondary to cancer
